The Effects Of Toy In Chıldren Durıng Inhaler Therapy

Bakirkoy Dr. Sadi Konuk Training and Research Hospital

Status: Completed

Conditions: Respiratory Disease; Lower Respiratory Tract Disease

Treatments: Other: using toy during inhaler treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT06924528

BakırköySadiKonuk-aboke-01

Details and patient eligibility

About

The purpose of the study is to investigate the effect of using a toy that children like during inhaler treatment on children's anxiety and emotional state. In the study, an inhaler treatment will be applied to children with a mask placed on a toy that they like. The purpose of this intervention is to reduce the child's anxiety and increase their emotional adjustment by improving adherence to the treatment.

Full description

Respiratory diseases are commonly seen during childhood. Today, inhaler medication is frequently used in the treatment of lower respiratory tract diseases. Inhalation therapy is the process of delivering liquid medication in aerosol form directly to the respiratory tract and lungs using devices called nebulizers. Compared to other treatment methods, the direct delivery of medication to the lungs, the rapid onset of effect, and fewer systemic side effects make inhalation therapy the preferred method for treating children. In treatments administered through inhalation, if the inhalation is being applied for the first time, the child may experience fear and anxiety due to not knowing the procedure. After the nurse explains how the procedure is done, they should use distraction techniques to relax the child and support the effective continuation of the inhalation treatment. Distraction techniques are simple and inexpensive methods, and studies have proven their positive effect on children. This study is designed to investigate the effect of using a toy during inhaler treatment on children's anxiety and emotional state.

Enrollment: 72 patients

Sex: All

Ages: 4 to 6 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• The child being between the ages of 4 and 6,
• The child being scheduled to receive their first inhaler treatment after admission to the unit,
• No IV or IM interventions being performed before the inhaler treatment,
• The child and parents being willing to participate in the study,
• No mental or neurological disabilities present in the child or parent,
• The child not having any life-threatening illnesses,
• The child having an oxygen saturation of 95% or higher,
• The child's body temperature not exceeding 37.5 degrees Celsius,
• The child's cognitive level and motor development being appropriate for their age,
• The child being able to count up to 10,
• The parent being literate,
• No visual or auditory problems present in the child or parent

Exclusion criteria

• The child's general condition (tachycardia, fever, vomiting, etc.) and orientation (disorientation, lethargy, etc.) significantly deteriorating after the inhaler treatment begins,
• The parent or child wanting to withdraw from the study at any stage of the research.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

72 participants in 2 patient groups

The control group

No Intervention group

Description:

5 minutes before starting the inhaler treatment, the child's anxiety level should be determined, and the child's emotional state should be evaluated by two observers. After washing hands, the aerosol medication ordered by the physician should be applied using a nebulizer mask. In the 5th minute after the inhaler treatment begins, the child's anxiety level should be determined, and the child's emotional state should be evaluated by two observers. 5 minutes after the inhaler treatment ends, the child's anxiety level should be determined, and the child's emotional state should be evaluated by two observers.

The intervention group

Experimental group

Description:

5 minutes before starting the inhaler treatment, the child's anxiety level should be determined, and the child's emotional state should be evaluated by two observers. After washing hands, the aerosol medication ordered by the physician should be applied using a nebulizer mask. The child is introduced to the plush toy of Kral Şakir, a character they recognize from cartoons. After explaining that King Şakir also needs help to recover, the nebulizer mask is applied to the toy, and saline solution is added to the mask's reservoir. Then, the treatment is started together with the child. In the 5th minute after the inhaler treatment begins, the child's anxiety level should be determined, and the child's emotional state should be evaluated by two observers. 5 minutes after the inhaler treatment ends, the child's anxiety level should be determined, and the child's emotional state should be evaluated by two observers.

Treatment:

Other: using toy during inhaler treatment